Related Experiment Video
Updated: Mar 6, 2026

05:30
Controlled Cortical Impact Model for Traumatic Brain Injury
Published on: August 5, 2014
29.8K
Network Reconstruction Reveals that Valproic Acid Activates Neurogenic Transcriptional Programs in Adult Brain
Gerald A Higgins1, Patrick Georgoff2, Vahagn Nikolian2
1Department of Computational Medicine and Bioinformatics, University of Michigan Medical School, Ann Arbor, Michigan, USA. gehiggin@med.umich.edu.
Pharmaceutical Research
|March 9, 2017
Summary
Valproic acid (VPA) promotes neurogenesis and neuroplasticity while suppressing gliogenesis and angiogenesis in the adult brain after traumatic brain injury (TBI) and hemorrhagic shock (HS). This study elucidates VPA's mechanism of action in CNS recovery.
Area of Science:
- Neuroscience
- Pharmacology
- Molecular Biology
Background:
- Traumatic brain injury (TBI) and hemorrhagic shock (HS) induce complex central nervous system (CNS) responses.
- Understanding the molecular mechanisms of therapeutic interventions is crucial for effective treatment.
Purpose of the Study:
- To elucidate the mechanism of action of valproic acid (VPA) in the adult CNS following TBI and HS.
- To identify the specific molecular pathways and gene regulations influenced by VPA.
Main Methods:
- Analysis of data from a porcine model, postmortem human brain samples, and existing literature.
- Utilized transcriptomic and epigenomic (Hi-C) analyses to map gene regulation.
- Investigated the role of key transcription factors (TFs) and their interactions.
Main Results:
- VPA treatment activates TFs promoting neurogenesis (e.g., MEF2D, NEUROD1) and suppresses gliogenesis.
- VPA represses genes involved in oligodendrogenesis, white matter maintenance, and angiogenesis.
- NEUROD1 is a key regulator, interacting with a significant portion of VPA-affected genes; GRIN2B SNP links to neurogenesis and neuroplasticity pathways.
Conclusions:
- VPA administration in the adult brain following TBI/HS promotes neurogenesis and neuroplasticity.
- VPA differentially activates specific TFs for neuronal fate and represses pathways related to oligodendrocyte differentiation and angiogenesis.
- This study reveals VPA's multifaceted mechanism in CNS injury recovery.

